AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Transcutaneous Spinal Cord Stimulation With Robotic Gait Training in Chronic SCI

RecruitingNAAges 21 Years - 65 YearsAllNational University Hospital, Singapore
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is aimed to evaluate whether transcutaneous spinal cord stimulation (tSCS) can augment robotic gait training (RGT) to improve functional mobility in participants with chronic spinal cord injuries. It also evaluate the impact of the tSCS+RGT on health-related quality of life (HRQOL), compared to RGT alone. This is a prospective single-arm crossover study in participants with incomplete chronic traumatic spinal cord injury. 6 subjects with paraplegia and 6 subjects with tetraplegia will be recruited. The intervention includes Phase 1 of training which consists of 16 sessions of robotic gait training (RGT) + conventional physiotherapy in 8-10 weeks, and Phase 2 of training which consists of 16 sessions of RGT training + tSCS + conventional physiotherapy in 8-10 weeks. Outcome measures including mobility function assessment and neuromuscular assessment will be collected at Basel

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Between 6 months to 5 years from the diagnosis of the traumatic SCI and who are not walking independently; 2. Age between 21 to 65 years old; 3. Incomplete spinal cord injury: ASIA Impairment Scale (AIS) Grade: B-D; 4. Spinal cord injury level: T1- L1, or C2-C8; 5. SCI-TCT Score \> 13; 6. Capable of providing an informed consent; 7. Cleared by Neurosurgeons/ Orthopeadic Surgeons for tSCS; 8. Meets prerequisites for Ekso wearable robotic exoskeleton training. Exclusion Criteria: 1. Participant has uncontrolled cardiopulmonary disease or cardiac symptoms as determined by the investigator; 2. Participant has any unstable or significant medical condition that is likely to interfere with study procedures or likely to confound performance and outcomes like uncontrolled neuropathic pain, depression, severe cognitive impairment; 3. Unstable or uncontrolled autonomic dysreflexia; 4. Requires ventilator support; 5. Spasms that limit the ability of the subjects to participate in the study training as determined by the investigator; 6. Skin conditions that limit the application of tSCS electrodes; 7. Active implanted medical devices that may be affected by tSCS; 8. Pregnant, planning to become pregnant or breastfeeding; 9. Concurrent participation in another drug or device trial that may interfere with this study; 10. Participated in wearable exoskeleton training within the last 3 months prior to enrolment. 11. Peripheral nerve injury or significant Lumbar Radiculopathy
๐Ÿ’Š

What it tests

  • RGT+ tSCS + conventional physiotherap
  • RGT+ conventional physiotherapy
๐Ÿ“

Where

1 site
Alexandra Hospital
Singapore, Singapore
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy